Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$940M |
| 2 |
Monster Beverage
MNST
|
+$698M |
| 3 |
CVS Health
CVS
|
+$501M |
| 4 |
Meta Platforms (Facebook)
META
|
+$370M |
| 5 |
Intercontinental Exchange
ICE
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$1.85B |
| 2 |
Salesforce
CRM
|
+$630M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$544M |
| 4 |
Capri Holdings
CPRI
|
+$358M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$352M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.12% |
| 2 | Technology | 14.75% |
| 3 | Financials | 14.22% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.89T
| $4.27B | 2.43% |
136,147,112
+3,183,012
| +2% | +$102M |
|
2
JPMorgan Chase
JPM
$939B
| $2.37B | 1.35% |
34,907,082
+991,525
| +3% | +$64.7M |
|
3
Microsoft
MSFT
$2.84T
| $2.22B | 1.26% |
50,227,071
+1,927,301
| +4% | +$87.9M |
|
|
4
CVS Health
CVS
$137B
| $2.04B | 1.16% |
19,460,352
+4,907,205
| +34% | +$501M |
|
5
Johnson & Johnson
JNJ
$635B
| $1.94B | 1.1% |
19,881,466
+1,488,439
| +8% | +$149M |
|
|
6
State Street SPDR S&P 500 ETF Trust
SPY
$778B
| $1.8B | 1.02% |
8,722,446
+4,470,872
| +105% | +$940M |
|
7
Alphabet (Google) Class C
GOOG
$3.9T
| $1.79B | 1.02% |
67,465,120
-2,853,772
| -4% | -$76.5M |
|
8
Comcast
CMCSA
$79.1B
| $1.79B | 1.02% |
59,493,958
-3,384,562
| -5% | -$99.4M |
|
9
Pfizer
PFE
$140B
| $1.77B | 1.01% |
55,594,949
-694,343
| -1% | -$22.6M |
|
|
10
Meta Platforms (Facebook)
META
$1.51T
| $1.71B | 0.97% |
19,939,958
+4,526,741
| +29% | +$370M |
|
11
Visa
V
$677B
| $1.54B | 0.87% |
22,879,392
+908,531
| +4% | +$61.6M |
|
12
Philip Morris
PM
$301B
| $1.52B | 0.87% |
18,983,813
+3,443,325
| +22% | +$283M |
|
13
Cisco
CSCO
$450B
| $1.52B | 0.86% |
55,252,169
+2,163,074
| +4% | +$62M |
|
14
Citigroup
C
$222B
| $1.43B | 0.81% |
25,905,588
-2,343,058
| -8% | -$127M |
|
15
Verizon
VZ
$194B
| $1.41B | 0.8% |
30,246,705
-191,809
| -0.6% | -$9.39M |
|
16
Wells Fargo
WFC
$261B
| $1.34B | 0.76% |
23,838,580
-1,929,817
| -7% | -$108M |
|
17
Bristol-Myers Squibb
BMY
$127B
| $1.26B | 0.72% |
18,900,505
-1,184,589
| -6% | -$78.1M |
|
|
CELG
18
DELISTED
Celgene Corp
CELG
| $1.24B | 0.71% |
10,748,270
-427,422
| -4% | -$48.9M |
|
19
Vertex Pharmaceuticals
VRTX
$121B
| $1.22B | 0.69% |
9,874,561
-81,333
| -0.8% | -$10.2M |
|
20
Amazon
AMZN
$2.5T
| $1.17B | 0.67% |
54,006,420
-4,619,940
| -8% | -$96.6M |
|
21
Mastercard
MA
$477B
| $1.17B | 0.66% |
12,475,735
+458,224
| +4% | +$42M |
|
22
Medtronic
MDT
$107B
| $1.15B | 0.65% |
15,473,855
-409,551
| -3% | -$31.3M |
|
23
Honeywell
HON
$77.1B
| $1.14B | 0.65% |
12,406,719
-429,649
| -3% | -$40.1M |
|
24
Merck
MRK
$324B
| $1.12B | 0.64% |
20,544,854
-3,489,598
| -15% | -$196M |
|
25
Altria Group
MO
$122B
| $1.1B | 0.63% |
22,582,438
+504,392
| +2% | +$25.6M |
|
Similar funds
Ameriprise's Q2 2015 Portfolio in Review
As of Q2 2015, Ameriprise held 4,343 positions worth $176B, up 0.84% from $174B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Ameriprise's Q2 2015 filing shows 422 new, 2,047 increased, 1,359 reduced and 277 closed positions. Its largest new stake was Allergan plc: 65,215 shares worth $68M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $1.85B.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Ameriprise's largest Q2 2015 buy was Allergan plc: 65,215 shares worth $68M.
- Ameriprise added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $940M increase.
- Ameriprise's biggest Q2 2015 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $1.85B.
- Ameriprise fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $333M.
- Ameriprise's ten largest holdings make up 12% of its $176B portfolio in Q2 2015.
- Ameriprise opened 422 new positions and closed 277 in Q2 2015.
- Ameriprise's portfolio value rose 0.84% quarter-over-quarter to $176B.
Based on Ameriprise's 13F filing for Q2 2015, filed 13 Aug 2015.